456.95
price up icon1.39%   6.27
pre-market  Pre-mercato:  456.95  
loading

Alnylam Pharmaceuticals Inc Borsa (ALNY) Ultime notizie

pulisher
03:44 AM

What drives Alnylam Pharmaceuticals Inc stock priceGlobal Trade Effects & Access Risk Ratings for Every Stock - earlytimes.in

03:44 AM
pulisher
Oct 09, 2025

KLP Kapitalforvaltning AS Has $16.01 Million Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Shell Asset Management Co. Purchases 1,602 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

What earnings revisions data tells us about Alnylam Pharmaceuticals Inc.Price Action & Expert Curated Trade Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Mirae Asset Global Investments Co. Ltd. Has $1.56 Million Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Oct 09, 2025
pulisher
Oct 08, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY) - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Alnylam’s AMVUTTRA Reduces GI Events in ATTR-CM Patients, According to New HELIOS-B Data - MSN

Oct 08, 2025
pulisher
Oct 08, 2025

Amyloidosis Clinical Market Outlook 2024-2034: Expanding Diagnostic Capabilities - openPR.com

Oct 08, 2025
pulisher
Oct 06, 2025

27 Analysts Assess Alnylam Pharmaceuticals: What You Need To Know - Benzinga

Oct 06, 2025
pulisher
Oct 06, 2025

Did Amvuttra’s Phase 3 Update and ZENITH Trial Milestone Just Shift Alnylam’s (ALNY) Investment Narrative? - simplywall.st

Oct 06, 2025
pulisher
Oct 06, 2025

Alnylam Pharmaceuticals (ALNY) Gets Target Price Boost from Morg - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

Morgan Stanley Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $475.00 - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Stifel Raises Price Target for ALNY; Maintains 'Buy' Rating | AL - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

Smart tools for monitoring Alnylam Pharmaceuticals Inc.’s price action2025 Bull vs Bear & Short-Term Trading Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $495.00 Price Target at Stifel Nicolaus - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Morgan Stanley Raises Price Target on Alnylam Pharmaceuticals to $475 From $405, Keeps Equalweight Rating - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Is Alnylam Pharmaceuticals Inc. (DUL) stock a top hedge fund pickWeekly Investment Recap & Smart Money Movement Tracker - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

News impact scoring models applied to Alnylam Pharmaceuticals Inc.Forecast Cut & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Alnylam Pharmaceuticals Inc a good long term investmentStraddle and Strangle Trades & Superior Wealth Growth - earlytimes.in

Oct 06, 2025
pulisher
Oct 05, 2025

Is Alnylam Pharmaceuticals Inc DUL a good long term investmentGlobal Trade Effects & Build Wealth Brick by Brick With Us - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Will Alnylam Pharmaceuticals Inc. (DUL) stock announce special dividendWeekly Loss Report & Accurate Intraday Trading Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What indicators show strength in Alnylam Pharmaceuticals Inc.Quarterly Profit Report & Advanced Swing Trade Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Alnylam Pharmaceuticals Inc. (DUL) stock attractive for dividend growth2025 Winners & Losers & Risk Managed Investment Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Alnylam Pharmaceuticals Inc. stock ready for breakout2025 Trade Ideas & High Win Rate Trade Tips - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Alnylam Pharmaceuticals (ALNY): Assessing Valuation After ZENITH Phase 3 Trial Launch and HELIOS-B Data Reveal - simplywall.st

Oct 04, 2025
pulisher
Oct 04, 2025

Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Set To Breakeven - Yahoo Finance

Oct 04, 2025
pulisher
Oct 04, 2025

AMF Tjanstepension AB Makes New $10.61 Million Investment in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Robeco Institutional Asset Management B.V. Trims Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded to Strong-Buy at Wall Street Zen - Defense World

Oct 04, 2025
pulisher
Oct 03, 2025

Kevin Joseph Fitzgerald Sells 2,441 Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Alnylam Pharmaceuticals (NASDAQ:ALNY) CEO Sells $4,034,094.20 in Stock - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Sells $1,364,372.56 in Stock - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Sells $1,727,283.05 in Stock - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Tolga Tanguler Sells 1,405 Shares - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Alnylam Pharma Secures $500M Credit Agreement - TipRanks

Oct 03, 2025
pulisher
Oct 03, 2025

Alnylam Pharmaceuticals says on Sept 30, entered into credit agreement with Bank of AmericaSEC filing - MarketScreener

Oct 03, 2025
pulisher
Oct 03, 2025

With Emma Walmsley exiting GSK, who will be pharma’s top women CEOs? - PharmaVoice

Oct 03, 2025
pulisher
Oct 03, 2025

Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by J. Safra Sarasin Holding AG - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Does Alnylam Pharmaceuticals Inc. show high probability of rebound2025 Sector Review & Growth Focused Stock Pick Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

8,322 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Purchased by Lbp Am Sa - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Is Alnylam Pharmaceuticals Inc. (DUL) stock overpriced at current multiplesJuly 2025 Sentiment & Fast Momentum Entry Tips - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Alnylam downgraded at Wolfe on doubts over Amvuttra growth - MSN

Oct 02, 2025
pulisher
Oct 02, 2025

Alnylam (ALNY) Reports 238% Growth in Amvuttra Since February Launch, RBC Raises Price Target - Yahoo Finance

Oct 02, 2025
pulisher
Oct 02, 2025

Alnylam Pulls TV Ad After Trump Crackdown on Drug Industry Spots - Bloomberg.com

Oct 02, 2025
pulisher
Oct 02, 2025

Alnylam Pharmaceuticals (ALNY) Pulls Ad After FDA Warning - GuruFocus

Oct 02, 2025
pulisher
Oct 02, 2025

Alnylam yanks Amvuttra TV ad following FDA letterreport - Seeking Alpha

Oct 02, 2025
pulisher
Oct 02, 2025

Cambridge-based Alnylam Pharmaceuticals pulls TV ad after Trump crackdown on drug industry spots - The Boston Globe

Oct 02, 2025
pulisher
Oct 02, 2025

Alnylam pulls heart drug TV ad amid FDA crackdown - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

Wealth Enhancement Slashes Alnylam Pharmaceuticals, Inc. (ALNY) Stake by 64.5% - MSN

Oct 02, 2025
pulisher
Oct 02, 2025

Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran - BioSpace

Oct 02, 2025
$569.90
price up icon 1.07%
$804.90
price up icon 0.75%
biotechnology ONC
$335.80
price down icon 4.36%
$164.40
price up icon 1.60%
$104.48
price down icon 1.69%
Capitalizzazione:     |  Volume (24 ore):